Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma

Cell Death & Disease, Published online: 04 March 2024; doi:10.1038/s41419-024-06553-5Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma

https://www.nature.com/articles/s41419-024-06553-5

Source: Cell death and disease - March 4, 2024 Category: Internal Medicine Authors: Xueou Yang Wenjun Wang Tianhai Ji Source Type: research

More News: Cancer & Oncology | Internal Medicine